BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 111840
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.111840
Table 3 Baseline cardiac function and biochemical measures, mean ± SD
Measures
Guanxinning intervention group (n = 60)
Control group (n = 60)
P values
ECG parameters
QTc interval (millisecond)462 ± 28465 ± 300.572
Echocardiographic indicators
LVEF (%)53.5 ± 4.953.2 ± 4.80.734
LVEDD (mm)52.3 ± 3.752.6 ± 3.80.658
E/A ratio, median (interquartile spacing)0.92 (0.81-1.05)0.90 (0.79-1.03)0.512
Serum biomarkers
cTnI (ng/mL), median (interquartile spacing)0.012 (0.008-0.018)0.013 (0.009-0.019)0.628
BNP (pg/mL), median (interquartile spacing)68 (45-95)72 (48-98)0.453
NT-proBNP (pg/mL), median (interquartile spacing)125 (85-180)132 (90-185)0.389
Indicators of oxidative stress
SOD (U/mL)85.3 ± 12.683.9 ± 13.10.545
MDA (nmol/mL)4.8 ± 1.25.0 ± 1.30.371
GSH-Px (U/L)168.5 ± 22.4165.8 ± 23.10.512
Inflammatory markers
Hs-CRP (mg/L), median (interquartile spacing)2.8 (1.5-4.6)3.0 (1.7-4.8)0.415
IL-6 (pg/mL), median (interquartile spacing)3.2 (2.1-4.8)3.4 (2.3-5.0)0.378
TNF-α (pg/mL), median (interquartile spacing)8.5 (6.2-11.3)8.8 (6.5-11.6)0.462
Metabolic indices
Fasting blood glucose (mmol/L)5.6 ± 0.85.5 ± 0.70.457
Total cholesterol (mmol/L)4.9 ± 0.95.0 ± 1.00.554
Triglycerides (mmol/L), median (interquartile spacing)1.8 (1.3-2.4)1.9 (1.4-2.5)0.389
HbA1c (%)5.8 ± 0.65.7 ± 0.50.312


Write to the Help Desk